CEO SUMMARY: Most clinical lab directors understand the risks that come with running a CLIA-licensed lab. Such risks are at the forefront of the criminal trial of Elizabeth Holmes, founder of now-defunct Theranos. During the trial, federal prosecutors and defense attorneys questioned four of Theranos’ former lab directors about inaccurate test results and failures to comply […]
In Theranos’ Trial, CLIA Laboratory Director Has a Starring Role
Who’s at fault? The lab director or Elizabeth Holmes?
- By Robert Michel
- > From the Volume XXVIII, No. 16 - November 29, 2021 Issue
- Tags: 2SD rule, Adam Rosendorff MD, Ars Technica, Centers for Medicare and Medicaid Services, clia, CLIA-licensed laboratory, Clinical Laboratory Improvement Amendments of 1988, CMS, Department of Justice, DOJ, Elizabeth Holmes, false claims act, Health Insurance Portability and Accountability Act of 1996, HIPAA, Kingshuk Das MD, Lynette Sawyer PhD, Matthew J. Murer JD, Medicaid, people, Polsinelli, Sunil Dhawan MD, The Wall Street Journal, Theranos, Tricare, U.S. District Court for the Northern District of California in San Jose
